The CBD oil market is expected to grow at a CAGR of 32.5% during the forecast period from 2025 to 2033, starting from US$ 1168.3 Mn in 2021. CBD oil-based products are gaining its popularity and consumers nowadays are becoming more inclined towards using CBD oil-based products for treating a number of health problems such as insomnia, chronic pain, anxiety, among others.
The global endotracheal tube market is projected to expand at a CAGR of 6.5% during the forecast period of 2025 to 2033. Increasing incidences of chronic diseases such as cardiovascular disease, cancer, and other respiratory diseases have led to an increase in the number of surgical procedures requiring endotracheal tubes. According to the 2019 World Health Organization report, respiratory diseases are the leading cause of death worldwide, accounting for approximately 4.0 million deaths annually.
Blockchain technology in healthcare is being acknowledged to have revolutionary impact on the healthcare system enabling its complete transformation through digitization. As digitization of all industries has continued to expand over the decades, the blockchain technology entered the market in 2016, despite its introduction in 2008. Blockchain technology has touched several industries deployed with vast information, technologies and artificial intelligence. The concept of blockchain represents a network of blocks that continuously grow and change, that adapt to specific industry. Blockchain is based on distributed ledgers containing facts and information.
The veterinary wearable devices market is set to reach from US$ 1,325.3 Mn in 2017 to US$ 3,704.6 Mn by 2026 at a compound annual growth rate (CAGR) of 12.1% during the forecast period from 2018 to 2026. It is noteworthy to understand that in the last decade internet of things (IoT) has played a crucial role in gathering and relaying of vital health statistics pertaining to human health. The same technology is being developed with respect to animals which helps veterinarians to gain useful clinical information for real time decision making in critical illness.
The veterinary biologics market is set to reach from US$ 21,953.8 Mn in 2021 to US$ 36,836.5 Mn by 2033 at a compound annual growth rate (CAGR) of 6.0% during the forecast period from 2025 to 2033. Veterinary biologics are medicinal products obtained from living organism and biological processes. They are employed in veterinary health science to diagnose, prevent and treat animal disease through immune-modulation.
The global varicose veins treatment devices market is increasing proficiently, expected to grow at a CAGR of 6.5%. Worldwide, the increasing burden of varicose veins along with improved therapeutic treatment options will drive the market growth. Around 40 million people in the U.S. suffer from varicose veins. Growing awareness about new sclerotherapy procedures, laser technology, and minimally invasive procedures to overcome the limitations by traditional procedures will increase the demand for advanced devices. Key factors such as increased expansion and acceptance for enzyme replacement therapy in the emerging nations, rising geriatric population, and U.S. FDA approvals for varicose veins treatment products will drive the overall market growth on a global scale.
The genital herpes treatment drugs market will be featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2025 to 2033. According to the latest research citing’s published by World Health Organization (WHO), approximately two-thirds of the global population under 50 years of age is infected with herpes simplex virus type 1 (HSV-1).
The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2025 to 2033, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics.
The global explosion-proof equipment market is expected to expand at a CAGR of 5.5% during the forecast period from 2025 to 2033. The anticipated growth in demand for explosion-proof systems can be largely credited to their widespread adoption among oil & gas, energy & mining, and industrial manufacturing verticals.
The ambulatory surgery centers market is projected to grow steadily with a CAGR of 7.5% over the forecast period from 2019 to 2029. The number of outpatients has increased significantly as a result of increased public health awareness and initiatives by the government to provide ambulatory healthcare services.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
